COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,950 Articles (22,604 medRxiv, 8,346 bioRxiv)

Most recent first Previous |  Page 1123: Articles 11221-11230  | Next

Quantifying the effects of non-pharmaceutical and pharmaceutical interventions against COVID-19 epidemic in the Republic of Korea: Mathematical model-based approach considering age groups and the Delta variant
Ko, Y., Mendoza, V. M. P., Seo, Y., Lee, J., Kim, Y., Kwon, D., Jung, E.
10.1101/2021.11.01.21265729 — Posted: 2021-11-01
Modelling COVID-19 Pandemic Dynamics Using Transparent, Interpretable, Parsimonious and Simulatable (TIPS) Machine Learning Models: A Case Study from Systems Thinking and System Identification Perspectives
Wei, H.-L., Billings, S. A.
10.1101/2021.11.01.21265653 — Posted: 2021-11-01
Underlying factors that influence the acceptance of COVID-19 vaccine in a country with a high vaccination rate
Toro-Ascuy, D., Cifuentes-Munoz, N., Avaria, A., Pereira-Montecinos, C., Cruzat, G., Zorondo-Rodriguez, F., Fuenzalida, L. F.
10.1101/2021.10.31.21265676 — Posted: 2021-11-01
Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies; A Multi-Center Prospective Study
Shehab, M., Alrashed, F., Alfadhli, A., Alotaibi, K., Alsahli, A., Mohammad, H., Cherian, P., Alkhairi, I., Thanaraj, T. A., Channanath, A., Ali, H., Abu-farha, M., Abubaker, J., Al-Mulla, F.
10.1101/2021.10.31.21265718 — Posted: 2021-11-01
Heterogenous pattern of the inflammasome-related markers in the critically ill COVID-19 patients at the ICU admission.
Adamik, B., Ambrozek-Latecka, M., Dragan, B., Jeznach, A., Smiechowicz, J., Gozdzik, W., Skirecki, T.
10.1101/2021.10.30.21265662 — Posted: 2021-11-01
Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020
Bogdanic, N., Mocibob, L., Vidovic, T., Soldo, A., Begovac, J.
10.1101/2021.10.31.21265714 — Posted: 2021-11-01
Automated Interpretable Discovery of Heterogeneous Treatment Effectiveness: A Covid-19 Case Study
Lengerich, B. J., Nunnally, M. E., Aphinyanaphongs, Y. J., Caruana, R.
10.1101/2021.10.30.21265430 — Posted: 2021-11-01
IFI27 transcription is an early predictor for COVID-19 outcomes; a multi-cohort observational study
Shojaei, M., Shamshirian, A., Monkman, J., Grice, L., Tran, M., Tan, C. W., Rossi, G. R., Mcculloch, T. R., Nalos, M., Chew, K. Y., Zhu, Y., Xia, Y., Wells, T. J., Senegaglia, A. C., Rebelatto, C. L., Franck, C. L., dos Santos, A. F., Noronha, L., Motamen, S., Valadan, R., Amjadi, O., Gogna, R., Madan, E., Alizadeh-Navaei, R., Lamperti, L., Zuniga, F., Nova-Lamperti, E., Labarca, G., Knippenberg, B., Herwanto, V., Wang, Y., Phu, A., Chew, T., Kwan, T., Kim, K., Teoh, S., Pelaia, T. M., Kuan, W. S., Jee, Y., Iredell, J., O'Byrne, K., Fraser, J. F., Davis, M. J., Belz, G. T., Warkiani, M. E., Salomon Gallo, C., Guimaraes, F. S., Nguyen, Q., Mclean, A., Kulasinghe, A., Short, K. R., Tang, B.
10.1101/2021.10.29.21265555 — Posted: 2021-11-01
Cross-border transmissions of delta substrain AY.29 during Olympic and Paralympic Games
Koyama, T., Tokumasu, R., Katayama, K., Saito, A., Kudo, M., Imoto, S.
10.1101/2021.10.31.21265711 — Posted: 2021-11-01
Chest X-ray Severity and its Association with Outcomes in Patients with COVID-19 Presenting to the Emergency Department
Kotok, D., Rivera Robles, J., Girard, C., Shettigar, S., Lavina, A., Gillenwater, S., Kim, A., Hadeh, A.
10.1101/2021.10.31.21265672 — Posted: 2021-11-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).